XML 53 R44.htm IDEA: XBRL DOCUMENT v3.22.2.2
Stockholders' Equity and Non-controlling Interests - Summary of the non-vested Restricted Stock (Details) - USD ($)
$ / shares in Units, $ in Thousands
3 Months Ended 9 Months Ended 12 Months Ended
Sep. 30, 2022
Sep. 30, 2021
Sep. 30, 2022
Sep. 30, 2021
Dec. 31, 2021
May 06, 2022
Oct. 29, 2021
May 07, 2021
Number of Shares                
Unvested at the beginning of the period (in shares)     297,000          
Granted (in shares)     149,000          
Vested (in shares)     (173,000)          
Forfeited (in shares)     (8,000)          
Unvested at the end of the period (in shares) 265,000   265,000   297,000      
Weighted Average Grant Date Fair Value                
Unvested at the beginning of the period (in dollars per share)     $ 8.87          
Granted (in dollars per share)     11.78          
Vested (in dollars per share)     8.17          
Forfeited (in dollars per share)     11.32          
Unvested at the end of the period (in dollars per share) $ 10.86   $ 10.86   $ 8.87      
Stock offering, maximum sales value           $ 100,000 $ 75,000  
Issuance of stock     $ 59          
Deferred offering costs incurred     100 $ 200        
Deferred offering costs $ 53   53   $ 40      
Murray Wise Associates, LLC ("MWA")                
Weighted Average Grant Date Fair Value                
Share-based compensation expense 0   400          
ATM Program                
Weighted Average Grant Date Fair Value                
Stock offering, maximum sales value 75,000   75,000       $ 75,000  
Net proceeds     $ 121,300          
Prior $50 million ATM Program                
Weighted Average Grant Date Fair Value                
Issuance of stock (in shares)     8,594,940          
Gross proceeds     $ 122,700          
Net proceeds     $ 121,300          
$75.0 million ATM Program                
Weighted Average Grant Date Fair Value                
Issuance of stock (in shares)     5,282,647          
Gross proceeds     $ 73,200          
Net proceeds     72,400          
$100.0 million ATM Program                
Weighted Average Grant Date Fair Value                
Stock offering, maximum sales value 100,000   $ 100,000     $ 100,000    
Issuance of stock (in shares)     3,312,293          
Gross proceeds     $ 49,500          
Net proceeds     48,900          
Restricted shares                
Weighted Average Grant Date Fair Value                
Share-based compensation expense 400 $ 300 1,600 $ 900        
Total unrecognized compensation costs related to non-vested stock awards $ 2,100   $ 2,100   $ 1,600      
Weighted average period over which unrecognized compensation costs is expected to be recognized     1 year 9 months 18 days          
Restricted shares | Third Amended Plan                
Weighted Average Grant Date Fair Value                
Maximum shares of common stock to be issued               1,900,000
Number of shares available for future grant 600,000   600,000